Friday, May 4, 2012

Directed Therapies in Lung Cancer: New Hope?

http://www.ncbi.nlm.nih.gov/pubmed/22551924


Arch Bronconeumol. 2012 Apr 30. [Epub ahead of print]

Directed Therapies in Lung Cancer: New Hope?

[Article in English, Spanish]

Source

Servicio de Neumología, Complexo Hospitalario Universitario de Ourense, Ourense, España.

Abstract

Lung cancer (LC) is a serious health problem due to its high incidence and mortality. Surgery is the most effective therapeutic strategy in this type of tumor, but in recent years new drugs are being investigated that target specific components of the tumor cells, improving survival in patients with advanced disease and relapse. We present a review of individualized treatments in LC, particularly therapies that inhibit epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) and anaplastic lymphoma kinase (ALK).

No comments:

Post a Comment